Prediction of response to biological treatment with monoclonal antibodies in severe asthma
Author:
Funder
Medical Centre Leeuwarden Science Fund, the Netherlands
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference131 articles.
1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014
2. Clinical phenotypes of asthma;Bel;Curr. Opin. Pulm. Med.,2004
3. New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!;Bel;Chest,2017
4. Horizonscangeneesmiddelen mepolizumab. 2019;2020.
5. de Groot JC, Ten Brinke A, Bel EH. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015;1:10.1183/23120541.00024,2015. eCollection 2015 May.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study;American Journal of Respiratory and Critical Care Medicine;2024-08-01
2. Strategies for Identifying Biomarkers in Severe Asthma;American Journal of Respiratory and Critical Care Medicine;2024-08-01
3. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database;BioDrugs;2024-03-15
4. Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study;Lung;2024-01-22
5. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry;European Respiratory Journal;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3